Xintela AB (Sweden) Today
| XINT Stock | SEK 0.28 0.01 3.45% |
Performance2 of 100
| Odds Of DistressOver 88
|
Xintela AB is selling for under 0.28 as of the 25th of April 2024; that is -3.45% down since the beginning of the trading day. The stock's last reported lowest price was 0.27. Xintela AB has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Xintela AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Xintela AB , a biomedical company, operates in the fields of regenerative medicine and cancer, focusing on cartilage damage and brain tumors. The company was founded in 2009 and is based in Lund, Sweden. Xintela AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. The company has 307.57 M outstanding shares. More on Xintela AB
Moving against Xintela Stock
| 0.48 | BIOA-B | BioArctic AB | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Xintela Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Xintela AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Xintela AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Evy LundgrenAkerlund |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Xintela AB (XINT) is traded on Stockholm Exchange in Sweden and employs 16 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 143.79 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Xintela AB's market, we take the total number of its shares issued and multiply it by Xintela AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Xintela AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 307.57 M outstanding shares.
Xintela AB has accumulated about 11.14 M in cash with (42.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Xintela AB Probability Of Bankruptcy
Ownership AllocationXintela AB retains a total of 307.57 Million outstanding shares. Xintela AB owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Xintela Ownership Details
Xintela Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Xintela AB jumping above the current price in 90 days from now is about 15.38%. The Xintela AB probability density function shows the probability of Xintela AB stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 2.0282. This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Xintela AB will likely underperform. Additionally, xintela AB has an alpha of 0.0862, implying that it can generate a 0.0862 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Xintela AB to move above the current price in 90 days from now is about 15.38 (This Xintela AB probability density function shows the probability of Xintela Stock to fall within a particular range of prices over 90 days) .
Xintela AB Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Xintela AB market risk premium is the additional return an investor will receive from holding Xintela AB long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Xintela AB. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Xintela AB's alpha and beta are two of the key measurements used to evaluate Xintela AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.54 | |||
| Semi Deviation | 3.38 | |||
| Standard Deviation | 4.63 | |||
| Variance | 21.48 |
Xintela Stock Against Markets
Picking the right benchmark for Xintela AB stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Xintela AB stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Xintela AB is critical whether you are bullish or bearish towards Xintela AB at a given time. Please also check how Xintela AB's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Xintela AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Xintela AB Corporate Directors
Xintela AB corporate directors refer to members of a Xintela AB board of directors. The board of directors generally takes responsibility for the Xintela AB's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Xintela AB's board members must vote for the resolution. The Xintela AB board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Peter Edman | Director | Profile | |
| Sven Kili | Director | Profile | |
| Liselotte Theorell | Director Product Development and Quality Management | Profile | |
| Keld Soendergaard | Director | Profile |
How to buy Xintela Stock?
Before investing in Xintela AB, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Xintela AB. To buy Xintela AB stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Xintela AB. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Xintela AB stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Xintela AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Xintela AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Xintela AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Xintela AB?
The danger of trading Xintela AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Xintela AB is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Xintela AB. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Xintela AB is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xintela AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Xintela Stock analysis
When running Xintela AB's price analysis, check to measure Xintela AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xintela AB is operating at the current time. Most of Xintela AB's value examination focuses on studying past and present price action to predict the probability of Xintela AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xintela AB's price. Additionally, you may evaluate how the addition of Xintela AB to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |